News
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Regulatory Expert Appointed to Lead West Coast US Client Engagement for G&L Healthcare Advisors
G&L Healthcare Advisors announces Richard Edmunds as new client engagement lead for U.S. West Coast business expansion in San Diego. The 25-year regulatory affairs veteran to expedite drug development and product launch for biotech and pharma companies -
-
-
-
COMMUNIQUÉ DE PRESSE
Communiqué de presse : ASCO : Sarclisa, en association avec un protocole VRd, est le premier anti-CD38 permettant d’améliorer significativement la survie sans progression des patients […]
Sarclisa associé à VRd améliore la survie sans progression chez les patients atteints de myélome multiple non éligibles à une transplantation, selon l'étude IMROZ publiée dans NEJM -
COMMUNIQUÉ DE PRESSE
Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3
Sarclisa in combo with VRd significantly enhances progression-free survival in newly diagnosed transplant-ineligible multiple myeloma in phase 3 study at ASCO. Full data published in NEJM
